These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31139325)

  • 1. Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma.
    Poon CC; Gordon PMK; Liu K; Yang R; Sarkar S; Mirzaei R; Ahmad ST; Hughes ML; Yong VW; Kelly JJP
    Oncotarget; 2019 May; 10(33):3129-3143. PubMed ID: 31139325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-Mutation in
    Barresi V; Simbolo M; Mafficini A; Piredda ML; Caffo M; Cardali SM; Germanò A; Cingarlini S; Ghimenton C; Scarpa A
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
    Williams EA; Miller JJ; Tummala SS; Penson T; Iafrate AJ; Juratli TA; Cahill DP
    Acta Neuropathol Commun; 2018 Oct; 6(1):106. PubMed ID: 30333046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
    Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
    Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
    Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
    Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between molecular characteristics of glioblastoma multiforme and the subventricular zone.
    Ashraf M; Abdelsadg M; Grivas A
    Br J Neurosurg; 2024 Oct; 38(5):1100-1107. PubMed ID: 35038937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    Karsy M; Guan J; Huang LE
    J Neurosurg; 2019 Jan; 130(1):56-66. PubMed ID: 29547090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.
    Wang PF; Song HW; Cai HQ; Kong LW; Yao K; Jiang T; Li SW; Yan CX
    Oncotarget; 2017 Jul; 8(30):50117-50123. PubMed ID: 28223536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival.
    Sun T; He Y; Li W; Liu G; Li L; Wang L; Xiao Z; Han X; Wen H; Liu Y; Chen Y; Wang H; Li J; Fan Y; Zhang W; Zhang J
    BMC Bioinformatics; 2021 Jul; 22(1):382. PubMed ID: 34301201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative transcriptome analysis identified a BMP signaling pathway-regulated lncRNA AC068643.1 in IDH mutant and wild-type glioblastomas.
    Huang GH; Pei YC; Yang L; Mou KJ; Tang JH; Xiang Y; Liu J; Lv SQ
    Oncol Lett; 2020 Jul; 20(1):75-84. PubMed ID: 32565936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival.
    Moreno DA; da Silva LS; Gomes I; Leal LF; Berardinelli GN; Gonçalves GM; Pereira CA; Santana IVV; Matsushita MM; Bhat K; Lawler S; Reis RM
    Ther Adv Med Oncol; 2022; 14():17588359221127678. PubMed ID: 36579028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
    Venteicher AS; Tirosh I; Hebert C; Yizhak K; Neftel C; Filbin MG; Hovestadt V; Escalante LE; Shaw ML; Rodman C; Gillespie SM; Dionne D; Luo CC; Ravichandran H; Mylvaganam R; Mount C; Onozato ML; Nahed BV; Wakimoto H; Curry WT; Iafrate AJ; Rivera MN; Frosch MP; Golub TR; Brastianos PK; Getz G; Patel AP; Monje M; Cahill DP; Rozenblatt-Rosen O; Louis DN; Bernstein BE; Regev A; Suvà ML
    Science; 2017 Mar; 355(6332):. PubMed ID: 28360267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.
    Takei H; Shinoda J; Ikuta S; Maruyama T; Muragaki Y; Kawasaki T; Ikegame Y; Okada M; Ito T; Asano Y; Yokoyama K; Nakayama N; Yano H; Iwama T
    J Neurosurg; 2020 Oct; 133(4):1010-1019. PubMed ID: 31419796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
    Engler JR; Robinson AE; Smirnov I; Hodgson JG; Berger MS; Gupta N; James CD; Molinaro A; Phillips JJ
    PLoS One; 2012; 7(8):e43339. PubMed ID: 22937035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma.
    Idoate Gastearena MA; López-Janeiro Á; Lecumberri Aznarez A; Arana-Iñiguez I; Guillén-Grima F
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study.
    Paldor I; Drummond KJ; Kaye AH
    J Clin Neurosci; 2016 Dec; 34():117-120. PubMed ID: 27522495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.